X
Anfarm Hellas S.A. - Main Section
Anfarm Hellas S.A. - Main Component
Active Substance |
Strength |
Form |
Caspofungin |
50mg, 70mg/Vial |
Pd.C.So.In |
Daptomycin |
350mg, 500mg/Vial |
Pd.I.S.Inf |
Ertapenem |
1g/Vial |
Pd.C.So.In |
Lacosamide |
10mg/ml |
Sol.Inf |
Palonosetron |
250mcg/5ml |
Inj.Sol |
Suggamadex |
100mg/ml |
Inj.Sol |
Tigecycline |
50mg/Vial |
Pd.Sol.Inf |
Active Substance |
Strength |
Form |
Caspofungin |
50mg, 70mg/Vial |
Pd.C.So.In |
Daptomycin |
350mg, 500mg/Vial |
Pd.I.S.Inf |
Ertapenem |
1g/Vial |
Pd.C.So.In |
Lacosamide |
10mg/ml |
Sol.Inf |
Palonosetron |
250mcg/5ml |
Inj.Sol |
Suggamadex |
100mg/ml |
Inj.Sol |
Tigecycline |
50mg/Vial |
Pd.Sol.Inf |
Active Substance |
Strength |
Form |
Dossier Availability |
Caspofungin |
50mg, 70mg/Vial |
Pd.C.So.In |
Q4 2018 |
Daptomycin |
350mg, 500mg/Vial |
Pd.I.S.Inf |
Q1 2020 |
Ertapenem |
1g/Vial |
Pd.C.So.In |
Q3 2019 |
Lacosamide |
10mg/ml |
Sol.Inf |
on going |
Palonosetron |
250mcg/5ml |
Inj.Sol |
Q2 2019 |
Suggamadex |
100mg/ml |
Inj.Sol |
on going |
Tigecycline |
50mg/Vial |
Pd.Sol.Inf |
on going |